PDC*line Pharma completes enrolment of four cohorts of patients in PDC-LUNG-101 phase I/II clinical trial
PDC*line Pharma completes enrolment of four cohorts of patients
in PDC-LUNG-101 phase I/II clinical trial.
Total of 67 patients dosed in four cohorts in PDC-LUNG-101 trial with PDC*lung01 therapeutic cancer vaccine candidate for non-small cell lung